TMS and CBT-I for comorbid depression and insomnia. Exploring feasibility and tolerability of transcranial magnetic stimulation (TMS) and cognitive behavioral therapy for insomnia (CBT-I) for comorbid major depressive disorder and insomnia during the COVID-19 pandemic

Michael A Norred, Lindsay C Haselden, Gregory L Sahlem, Allison K Wilkerson, E Baron Short, Lisa M McTeague, Mark S George, Michael A Norred, Lindsay C Haselden, Gregory L Sahlem, Allison K Wilkerson, E Baron Short, Lisa M McTeague, Mark S George

No abstract available

Keywords: CBTI; Cognitive behavioral therapy for insomnia; Depression; Insomnia; TMS; Transcranial magnetic stimulation.

Conflict of interest statement

Declaration of competing interest None.

References

    1. Franzen PL, Buysse DJ. Sleep disturbances and depression: risk relationships for subsequent depression and therapeutic implications. Dialogues Clin Neurosci 2008;10(4):473–81.
    1. Stewart R, Besset A, Bebbington P, Brugha T, Lindesay J, Jenkins R, Singleton N, Meltzer H. Insomnia comorbidity and impact and hypnotic use by age group in a national survey population aged 16 to 74 years. Sleep 2006;29(11): 1391–7.
    1. Soehner AM, Kaplan KA, Harvey AG. Prevalence and clinical correlates of cooccurring insomnia and hypersomnia symptoms in depression. J Affect Disord 2014;167:93–7.
    1. Cutler AJ. The role of insomnia in depression and anxiety: its impact on functioning, treatment, and outcomes. J Clin Psychiatr 2016;77(8):e1010.
    1. Nierenberg AA, Husain MM, Trivedi MH, Fava M, Warden D, Wisniewski SR, Miyahara S, Rush AJ. Residual symptoms after remission of major depressive disorder with citalopram and risk of relapse: a STAR*D report. Psychol Med 2010;40(1):41–50.
    1. Lefaucheur JP, Aleman A, Baeken C, Benninger DH, Brunelin J, Di Lazzaro V, Filipovic SR, Grefkes C, Hasan A, Hummel FC, Jaaskelainen SK, Langguth B, Leocani L, Londero A, Nardone R, Nguyen JP, Nyffeler T, Oliveira-Maia AJ, Oliviero A, Padberg F, Palm U, Paulus W, Poulet E, Quartarone A, Rachid F, Rektorova I, Rossi S, Sahlsten H, Schecklmann M, Szekely D, Ziemann U. Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS): an update (2014–2018). Clin Neurophysiol 2020;131(2):474–528.
    1. Rosenquist PB, Krystal A, Heart KL, Demitrack MA, McCall WV. Left dorsolateral prefrontal transcranial magnetic stimulation (TMS): sleep factor changes during treatment in patients with pharmacoresistant major depressive disorder. Psychiatr Res 2013;205(1–2):67–73.
    1. Carney CE, Edinger JD, Kuchibhatla M, Lachowski AM, Bogouslavsky O, Krystal AD, Shapiro CM. Cognitive behavioral insomnia Therapy for those with insomnia and depression: a randomized controlled clinical trial. Sleep 2017;40(4).
    1. Stultz DJ, Osburn S, Burns T, Pawlowska-Wajswol S, Walton R. Transcranial magnetic stimulation (tms) safety with respect to seizures: a literature review. Neuropsychiatric Dis Treat 2020;16:2989–3000.
    1. Taylor DJ, Peterson AL, Goodie JL, Grieser E, Hryshko-Mullen AS, Rowan A, Wilkerson A, Pruiksma KE, Dietch JR, Hall-Clark B, Fina B. Cognitive behavioral Therapy for insomnia in the military: therapist guide. 2019. Retrieved from, .

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe